دورية أكاديمية

Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis

التفاصيل البيبلوغرافية
العنوان: Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
المؤلفون: Maria N. Chamurlieva, Yulia L. Korsakova, Stefka G. Radenska-Lopovok, Tatiana V. Korotaeva
المصدر: Vestnik Dermatologii i Venerologii, Vol 97, Iss 4, Pp 113-119 (2021)
بيانات النشر: State Scientific Center of Dermatovenereology and Cosmetology, 2021.
سنة النشر: 2021
المجموعة: LCC:Dermatology
مصطلحات موضوعية: cutaneous vasculitis, etanercept, biologic dmards, case report, rheumatoid arthritis, Dermatology, RL1-803
الوصف: Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the treatment of chronic inflammatory rheumatic diseases. Since the introduction of tumor necrosis factor alpha (TNF-) inhibitors, the treatment of rheumatoid arthritis has been revolutionized. The approach of targeting TNF- has considerably improved the success of the treatment of rheumatoid arthritis. Their effectiveness has been extensively proven in randomized clinical trials and in clinical practice. Randomized clinical trials and post-marketing studies proved that patients undergoing TNF- inhibitors therapy are at increased risk of infectious disease, bacterial, viral, fungal, opportunistic, oncology and skin adverse effects such as psoriasis and angiitis of the skin. In this case report drug-induced cutaneous vasculitis developing during TNF- inhibitor (Etanercept) treatment for rheumatoid arthritis is described.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Russian
تدمد: 0042-4609
2313-6294
Relation: https://vestnikdv.ru/jour/article/viewFile/1233/1222; https://doaj.org/toc/0042-4609; https://doaj.org/toc/2313-6294
DOI: 10.25208/vdv1233
URL الوصول: https://doaj.org/article/91175d6222fa48c88b9edfe7b48b771d
رقم الأكسشن: edsdoj.91175d6222fa48c88b9edfe7b48b771d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00424609
23136294
DOI:10.25208/vdv1233